Literature DB >> 23391734

STAT2 deficiency and susceptibility to viral illness in humans.

Sophie Hambleton1, Stephen Goodbourn, Dan F Young, Paul Dickinson, Siti M B Mohamad, Manoj Valappil, Naomi McGovern, Andrew J Cant, Scott J Hackett, Peter Ghazal, Neil V Morgan, Richard E Randall.   

Abstract

Severe infectious disease in children may be a manifestation of primary immunodeficiency. These genetic disorders represent important experiments of nature with the capacity to elucidate nonredundant mechanisms of human immunity. We hypothesized that a primary defect of innate antiviral immunity was responsible for unusually severe viral illness in two siblings; the proband developed disseminated vaccine strain measles following routine immunization, whereas an infant brother died after a 2-d febrile illness from an unknown viral infection. Patient fibroblasts were indeed abnormally permissive for viral replication in vitro, associated with profound failure of type I IFN signaling and absence of STAT2 protein. Sequencing of genomic DNA and RNA revealed a homozygous mutation in intron 4 of STAT2 that prevented correct splicing in patient cells. Subsequently, other family members were identified with the same genetic lesion. Despite documented infection by known viral pathogens, some of which have been more severe than normal, surviving STAT2-deficient individuals have remained generally healthy, with no obvious defects in their adaptive immunity or developmental abnormalities. These findings imply that type I IFN signaling [through interferon-stimulated gene factor 3 (ISGF3)] is surprisingly not essential for host defense against the majority of common childhood viral infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23391734      PMCID: PMC3581986          DOI: 10.1073/pnas.1220098110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

2.  Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

Authors:  P Hardelid; N J Andrews; K Hoschler; E Stanford; M Baguelin; P A Waight; M Zambon; E Miller
Journal:  Health Technol Assess       Date:  2010-12       Impact factor: 4.014

3.  Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency.

Authors:  Vanessa Sancho-Shimizu; Rebeca Pérez de Diego; Lazaro Lorenzo; Rabih Halwani; Abdullah Alangari; Elisabeth Israelsson; Sylvie Fabrega; Annabelle Cardon; Jerome Maluenda; Megumi Tatematsu; Farhad Mahvelati; Melina Herman; Michael Ciancanelli; Yiqi Guo; Zobaida AlSum; Nouf Alkhamis; Abdulkarim S Al-Makadma; Ata Ghadiri; Soraya Boucherit; Sabine Plancoulaine; Capucine Picard; Flore Rozenberg; Marc Tardieu; Pierre Lebon; Emmanuelle Jouanguy; Nima Rezaei; Tsukasa Seya; Misako Matsumoto; Damien Chaussabel; Anne Puel; Shen-Ying Zhang; Laurent Abel; Saleh Al-Muhsen; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

4.  The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation.

Authors:  L Didcock; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.

Authors:  Stéphanie Dupuis; Emmanuelle Jouanguy; Sami Al-Hajjar; Claire Fieschi; Ibrahim Zaid Al-Mohsen; Suliman Al-Jumaah; Kun Yang; Ariane Chapgier; Céline Eidenschenk; Pierre Eid; Abdulaziz Al Ghonaium; Haysam Tufenkeji; Husn Frayha; Suleiman Al-Gazlan; Hassan Al-Rayes; Robert D Schreiber; Ion Gresser; Jean-Laurent Casanova
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

6.  Heterocellular induction of interferon by negative-sense RNA viruses.

Authors:  S Chen; J A L Short; D F Young; M J Killip; M Schneider; S Goodbourn; R E Randall
Journal:  Virology       Date:  2010-09-15       Impact factor: 3.616

7.  Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.

Authors:  Friedemann Weber; Anne Bridgen; John K Fazakerley; Hein Streitenfeld; Nina Kessler; Richard E Randall; Richard M Elliott
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Role of STAT2 in the alpha interferon signaling pathway.

Authors:  S Leung; S A Qureshi; I M Kerr; J E Darnell; G R Stark
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

Review 9.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

10.  STAT2 hypomorphic mutant mice display impaired dendritic cell development and antiviral response.

Authors:  Lan-Sun Chen; Pei-Chi Wei; Taming Liu; Chung-Hsuan Kao; Li-Mei Pai; Chien-Kuo Lee
Journal:  J Biomed Sci       Date:  2009-02-19       Impact factor: 8.410

View more
  108 in total

Review 1.  Within host RNA virus persistence: mechanisms and consequences.

Authors:  Richard E Randall; Diane E Griffin
Journal:  Curr Opin Virol       Date:  2017-03-17       Impact factor: 7.090

2.  Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters.

Authors:  Colm Atkins; Jinxin Miao; Birte Kalveram; Terry Juelich; Jennifer K Smith; David Perez; Lihong Zhang; Jonna L B Westover; Arnaud J Van Wettere; Brian B Gowen; Zhongde Wang; Alexander N Freiberg
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

Review 3.  Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.

Authors:  Helen L Storr; Sumana Chatterjee; Louise A Metherell; Corinne Foley; Ron G Rosenfeld; Philippe F Backeljauw; Andrew Dauber; Martin O Savage; Vivian Hwa
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

4.  An alternatively transcribed TAZ variant negatively regulates JAK-STAT signaling.

Authors:  Chuantao Fang; Jian Li; Sixian Qi; Yubin Lei; Yan Zeng; Pengcheng Yu; Zhaolan Hu; Yufeng Zhou; Yulong Wang; Ruping Dai; Jin Li; Shenglin Huang; Pinglong Xu; Kang Chen; Chen Ding; Fa-Xing Yu
Journal:  EMBO Rep       Date:  2019-04-11       Impact factor: 8.807

Review 5.  The JAK-STAT pathway: impact on human disease and therapeutic intervention.

Authors:  John J O'Shea; Daniella M Schwartz; Alejandro V Villarino; Massimo Gadina; Iain B McInnes; Arian Laurence
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

6.  A novel variant in STAT2 presenting with hemophagocytic lymphohistiocytosis.

Authors:  Mohammed F Alosaimi; Michelle C Maciag; Craig D Platt; Raif S Geha; Janet Chou; Lisa M Bartnikas
Journal:  J Allergy Clin Immunol       Date:  2019-05-15       Impact factor: 10.793

Review 7.  New immunodeficiency syndromes that help us understand the IFN-mediated antiviral immune response.

Authors:  Huie Jing; Helen C Su
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

8.  Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.

Authors:  Wen Li; Markus J Hofer; Pattama Songkhunawej; So Ri Jung; Dale Hancock; Gareth Denyer; Iain L Campbell
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

Review 9.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

Review 10.  The Ying and Yang of STAT3 in Human Disease.

Authors:  Tiphanie P Vogel; Joshua D Milner; Megan A Cooper
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.